{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:48:42Z","timestamp":1787759322655,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18K06795"],"award-info":[{"award-number":["JP18K06795"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11095-021-03140-7","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T23:02:47Z","timestamp":1638399767000},"page":"1839-1846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics\/Pharmacodynamics Experiments"],"prefix":"10.1007","volume":"38","author":[{"given":"Wataru","family":"Takemura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Enoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"issue":"5","key":"3140_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.mcna.2018.04.005","volume":"102","author":"EJ Septimus","year":"2018","unstructured":"Septimus EJ. Antimicrobial resistance an antimicrobial\/diagnostic stewardship and infection prevention approach. Med Clin North Am. 2018;102(5):819\u201329.","journal-title":"Med Clin North Am"},{"issue":"3","key":"3140_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2165\/11533040-000000000-00000","volume":"70","author":"JDD Pitout","year":"2010","unstructured":"Pitout JDD. Infections with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae changing epidemiology and drug treatment choices. Drugs. 2010;70(3):313\u201333.","journal-title":"Drugs"},{"issue":"7643","key":"3140_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nature.2017.21550","volume":"543","author":"C Willyard","year":"2017","unstructured":"Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017;543(7643):15.","journal-title":"Nature"},{"issue":"1036","key":"3140_CR4","first-page":"321","volume":"289","author":"RP Ambler","year":"1980","unstructured":"Ambler RP. The structure of \u03b2-lactamases. Philos Trans R Soc London. 1980;289(1036):321\u201331.","journal-title":"Philos Trans R Soc London"},{"issue":"3","key":"3140_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/AAC.01009-09","volume":"54","author":"K Bush","year":"2010","unstructured":"Bush K, Jacoby GA. Updated functional classification of-lactamases. Antimicrob Agents Chemother. 2010;54(3):969\u201376.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3140_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.00079-17","volume":"31","author":"J Rodr\u00edguez-Ba\u00f1o","year":"2018","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Guti\u00e9rrez-Guti\u00e9rrez B, Machuca I, Pascual A. Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev. 2018;31(2):1\u201342.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"3140_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA. Extended-spectrum-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657\u201386.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"3140_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","volume":"8","author":"D van Duin","year":"2017","unstructured":"van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8(4):460\u20139.","journal-title":"Virulence"},{"key":"3140_CR9","unstructured":"World Health Organization. Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. 2017. https:\/\/apps.who.int\/iris\/handle\/10665\/259462. Accessed 23 Jul 2021."},{"issue":"Suppl D","key":"3140_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/23.suppl_D.1","volume":"23","author":"RN Jones","year":"1989","unstructured":"Jones RN. Review of the in-vitro spectrum and characteristics of cefmetazole (CS-1170). J Antimicrob Chemother. 1989;23(Suppl D):1\u201312.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"3140_CR11","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/AAC.34.5.858","volume":"34","author":"GA Jacoby","year":"1990","unstructured":"Jacoby GA, Carreras I. Activities of \u03b2-Lactam Antibiotics against Escherichia coli Strains Producing Extended-Spectrum \u03b2-Lactamases. Antimicrob Agents Chemother. 1990;34(5):858\u201362.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"3140_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijantimicag.2014.11.012","volume":"45","author":"Q Yang","year":"2015","unstructured":"Yang Q, Zhang H, Cheng J, Xu Z, Xu Y, Cao B, et al. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum \u03b2-lactamases in China. Int J Antimicrob Agents. 2015;45(5):485\u201390.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"3140_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.diagmicrobio.2015.12.001","volume":"84","author":"Y Matsumura","year":"2016","unstructured":"Matsumura Y, Yamamoto M, Nagao M, Tanaka M, Takakura S, Ichiyama S. In vitro activities and detection performances of cefmetazole and flomoxef for extended-spectrum \u03b2-lactamase and plasmid-mediated AmpC \u03b2-lactamase-producing Enterobacteriaceae. Diagn Microbiol Infect Dis. 2016;84(4):322\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"9","key":"3140_CR14","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1128\/AAC.00701-15","volume":"59","author":"Y Matsumura","year":"2015","unstructured":"Matsumura Y, Yamamoto M, Nagao M, Komori T, Fujita N, Hayashi A, et al. Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-lactamase-producing Escherichia coli bacteremia. Antimicrob Agents Chemother. 2015;59(9):5107\u201313.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3140_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1086\/510079","volume":"44","author":"PG Ambrose","year":"2007","unstructured":"Ambrose PG, Bhavnani SM, Rubino CM, Louie A, Gumbo T, Forrest A, et al. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It\u2019s not just for mice anymore. Clin Infect Dis. 2007;44(1):79\u201386.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3140_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/516284","volume":"26","author":"WA Craig","year":"1998","unstructured":"Craig WA. Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1\u201310.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3140_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11095-020-02977-8","volume":"38","author":"S Tashiro","year":"2021","unstructured":"Tashiro S, Hayashi M, Takemura W, Igarashi Y, Liu X, Mizukami Y, et al. Pharmacokinetics\/pharmacodynamics evaluation of flomoxef against extended-spectrum beta-lactamase-producing Escherichia coli in vitro and in vivo in a murine thigh infection model. Pharm Res. 2021;38(1):27\u201335.","journal-title":"Pharm Res"},{"key":"3140_CR18","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 10th edition. CLSI document M07\u2013A10","author":"Clinical and Laboratory Standards Institute","year":"2015","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 10th edition. CLSI document M07\u2013A10. Wayne: CLSI; 2015."},{"key":"3140_CR19","volume-title":"Performance standards for antimicrobial susceptibility testing: 30th edition. CLSI supplement M100","author":"Clinical and Laboratory Standards Institute","year":"2020","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 30th edition. CLSI supplement M100. Wayne: CLSI; 2020."},{"key":"3140_CR20","volume-title":"Methods for determining bactericidal activity of antimicrobial agents; approved guideline. CLSI document M26-A","author":"Clinical and Laboratory Standards Institute","year":"1999","unstructured":"Clinical and Laboratory Standards Institute. Methods for determining bactericidal activity of antimicrobial agents; approved guideline. CLSI document M26-A. Wayne: CLSI; 1999."},{"issue":"4","key":"3140_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1128\/AAC.34.4.519","volume":"34","author":"CE Halstenson","year":"1990","unstructured":"Halstenson CE, Guay DRP, Opsahl JA, Hirata CAI, Olanoff LS, Novak E, et al. Disposition of cefmetazole in healthy volunteers and patients with impaired renal function. Antimicrob Agents Chemother. 1990;34(4):519\u201323.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"3140_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1469-0691.2007.01867.x","volume":"14","author":"GM Rossolini","year":"2008","unstructured":"Rossolini GM, D\u2019Andrea MM, Mugnaioli C. The spread of CTX-M-type extended-spectrum \u03b2-lactamases. Clin Microbiol Infect. 2008;14(Suppl 1):33\u201341.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"3140_CR23","doi-asserted-by":"publisher","first-page":"e00603","DOI":"10.1128\/AAC.00603-19","volume":"63","author":"L McEntee","year":"2019","unstructured":"McEntee L, Johnson A, Farrington N, Unsworth J, Dane A, Jain A, et al. Pharmacodynamics of tebipenem: new options for oral treatment of multidrug-resistant gram-negative infections. Antimicrob Agents Chemother. 2019;63(8):e00603-e619.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3140_CR24","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1128\/AAC.00476-17","volume":"61","author":"AJ Lepak","year":"2017","unstructured":"Lepak AJ, Zhao M, Vanscoy B, Taylor DS, Ellis-Grosse E, Ambrose PG, et al. In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017;61(6):476\u2013517.","journal-title":"Antimicrob Agents Chemother"},{"issue":"16","key":"3140_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0196-4399(91)90030-Y","volume":"13","author":"WA Craig","year":"1991","unstructured":"Craig WA. The postantibiotic effect. Clin Microbiol Newsl. 1991;13(16):121\u20134.","journal-title":"Clin Microbiol Newsl"},{"issue":"8","key":"3140_CR26","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/jac\/dkx146","volume":"72","author":"ER Bevan","year":"2017","unstructured":"Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M \u03b2-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72(8):2145\u201355.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"3140_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1089\/mdr.2014.0083","volume":"21","author":"K Osawa","year":"2015","unstructured":"Osawa K, Shigemura K, Shimizu R, Kato A, Kusuki M, Jikimoto T, et al. Molecular characteristics of extended-spectrum \u03b2-lactamase-producing Escherichia coli in a university teaching hospital. Microb Drug Resist. 2015;21(2):130\u20139.","journal-title":"Microb Drug Resist"},{"issue":"10","key":"3140_CR28","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s00134-015-4188-0","volume":"42","author":"MH Abdul-Aziz","year":"2016","unstructured":"Abdul-Aziz MH, Sulaiman H, Mat-Nor MB, Rai V, Wong KK, Hasan MS, et al. Beta-lactam infusion in severe sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. Intensive Care Med. 2016;42(10):1535\u201345.","journal-title":"Intensive Care Med"},{"key":"3140_CR29","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ijid.2020.11.176","volume":"103","author":"M Akahane","year":"2021","unstructured":"Akahane M, Enoki Y, Saiki R, Hayashi Y, Hiraoka K, Honma K, et al. Stability of antimicrobial agents in an elastomeric infusion pump used for outpatient parenteral antimicrobial therapy. Int J Infect Dis. 2021;103:464\u20138.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"3140_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12879-016-1770-1","volume":"16","author":"T Fukuchi","year":"2016","unstructured":"Fukuchi T, Iwata K, Kobayashi S, Nakamura T, Ohji G. Cefmetazole for bacteremia caused by ESBL-producing Enterobacteriaceae comparing with carbapenems. BMC Infect Dis. 2016;16(1):427.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3140_CR31","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1515\/med-2020-0103","volume":"15","author":"T Kuwana","year":"2020","unstructured":"Kuwana T, Yamaguchi J, Kinoshita K, Hori S, Ihara S, Taniguchi T. Case report successful de-escalation antibiotic therapy using cephamycins for sepsis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia: A sequential 25-case series. Open Med. 2020;15(1):782\u20136.","journal-title":"Open Med"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-021-03140-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-021-03140-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-021-03140-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T17:16:11Z","timestamp":1640020571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-021-03140-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["3140"],"URL":"https:\/\/doi.org\/10.1007\/s11095-021-03140-7","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}